Work

Second interim analysis of the Global Investigation of Therapeutic Decisions in Unresectable HCC (uHCC) and of Its Treatment with Sorafenib (GIDEON): Differences in AE reporting across physician specialties.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.4_suppl.286

Authors: Alan Paul Venook, Riccardo Lencioni, Jorge A. Marrero, Masatoshi Kudo, Keiko Nakajima, Sheng-Long Ye, Frank Cihon

Institutions: University of California, San Francisco, Fudan University, University of Michigan, Zhongshan Hospital, Kindai University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2584800696

Cites:

Cited by: 1

Related to: 10